Advanced search×

Bleeding duodenal ulcer. A prospective evaluation of risk factors for rebleeding and death.

Ann Surg 211(4):411-8 (1990) PMID 2322036 PMCID 1358026

There were 12 hospital deaths in 433 patients (2.8%, 1.6% at 30 days) presenting with bleeding duodenal ulcer. Excluding patients who underwent immediate operation or early elective surgery, where ulcer size was measured at initial endoscopy rebleeding was evident in 40/288 patients (13.9%) and was associated with an increased mortality (0.4% v 12.5%) (p less than 0.0001). Rebleeding rates for ulcers less than or equal to 1 cm and greater than 1 cm were respectively 28/239 (11.7%) and 12/49 (24.5%) (p less than 0.02). Rebleeding occurred in 13/186 patients (7.0%) in whom endoscopic stigmata of recent haemorrhage were absent and in 27/102 (26.5%) with such stigmata (p less than 0.0001). The mortality rate for patients without stigmata was 3/186 (1.6%) whilst mortality figures for patients with ulcers less than or equal to 1 cm and greater than 1 cm in size were respectively 0/77 and 3/25 (12.0%) when stigmata were identified. Ulcers greater than 1 cm were more frequent in the greater than 60 year age group, more likely to have stigmata and carried an increased risk of rebleeding and mortality.

Version: za2963e q8za6 q8zb0 q8zc3 q8zdc q8zea q8zfc q8zgd

Similar articles you may find interesting…

  1. Risk for rebleeding of the duodenal bulbar ulcer is less than that of the gastric ulcer.

    Am J Gastroenterol 91(6):1290-1 (1996) PMID 8651213

  2. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers.

    Am J Gastroenterol 103(10):2625-32; quiz 2633 (2008) PMID 18684171

    The independent predictors of recurrent hemorrhage after endoscopic therapy, particularly those that are the strongest and most consistent in the literature, may be used to select patients who are most likely to benefit from aggressive post-hemostasis care, including intensive care unit (ICU) observ...